CP
Catalys Pacific Portfolio holdings
AUM
$132M
This Quarter Return
-4.02%
1 Year Return
+28.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$107M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$79.1M |
| 2 |
HilleVax
HLVX
|
$21M |
| 3 |
Phathom Pharmaceuticals
PHAT
|
$6.59M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Mineralys Therapeutics
MLYS
$1.03B
| $79.1M | 74.13% |
+9,194,579
| New | +$79.1M |
|
|
2
HilleVax
HLVX
$105M
| $21M | 19.69% |
+1,308,974
| New | +$21M |
|
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $6.59M | 6.18% |
+721,962
| New | +$6.59M |
|